Analysis of the Economic and Socio-Demographic Burden of HPV-Associated Diseases and the Cost-Effectiveness of HPV Vaccination in Russia
Background.The human papillomavirus (HPV) is one of the most common sexually transmitted viruses and, according to WHO, the cause of 7.5% of all women deaths from cancer. Every year, more than 500.000 new cases of HPV-associated cancer are registered in the world, approximately 90% of which fall int...
Main Authors: | Alexander A. Baranov, Alexander V. Plakida, Leyla S. Namazova-Baranova, Mikhail A. Semenov, Olga V. Ilyushina, Yevgeniy V. Guretskiy, Marina V. Fedoseenko, Alla V. Rudakova |
---|---|
Format: | Article |
Language: | English |
Published: |
Paediatrician Publishers, LLC
2019-06-01
|
Series: | Pediatričeskaâ Farmakologiâ |
Subjects: | |
Online Access: | https://www.pedpharma.ru/jour/article/view/1723 |
Similar Items
-
Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine
by: Noelia López, et al.
Published: (2018-05-01) -
HPV knowledge of college females and their intention to receive the HPV vaccination
by: Smith, Lisa G.
Published: (2011) -
Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe
by: Susanne Hartwig, et al.
Published: (2017-04-01) -
Prophylactic HPV vaccines
by: Mandić Aljoša
Published: (2009-01-01) -
The results of genotyping in HPV-associated cervical infection
by: T V Klinyshkova, et al.
Published: (2016-06-01)